Planetica 50 Injection
Marketer
Axiommax Oncology Pvt Ltd
Salt Composition
Cisplatin (50mg)
Overview Planetica 50 Injection
OncoPlan 50 Injection, a prescription medication, treats ovarian, cervical, and testicular cancers. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include injection site inflammation (pain, swelling, redness), nausea, and vomiting. Serious side effects include hearing impairment; pre- and ongoing hearing assessments are therefore crucial. The medication can lower blood cell counts (red and white), increasing infection risk, necessitating regular blood tests to monitor blood cell levels and kidney, liver, and heart function. Prior to treatment, disclose any history of kidney disease, as the drug can impact renal function. Inform your healthcare provider of all other medications you are taking due to potential drug interactions. This injection is contraindicated during pregnancy and breastfeeding. Male infertility is a possibility; sperm banking should be considered before commencing therapy.
Primary Ingredients of Planetica 50 Injection
There is no text provided to rephrase.
Uses of Planetica 50 Injection
Cancers affecting the ovaries, cervix, and testes.
Major Benefits of Planetica 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Planetica 50 Injection:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Planetica 50 Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Planetica 50 Injection works:
Onco-Planetica 50 Injection is an antineoplastic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) of cancerous cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Planetica 50 Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Planetica 50 Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the risks, justifying its prescription. Seek medical advice before use.
Breast feedingUNSAFE
Administration of Planetica 50 Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Administration of Planetica 50 Injection may induce adverse reactions, potentially impairing driving ability. These reactions can include drowsiness and/or nausea, impacting safe operation of a vehicle.
KidneyCAUTION
Individuals with impaired kidney function should use Planetica 50 Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Planetica 50 Injection is contraindicated in patients exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Planetica 50 Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may not be necessary; however, medical advice is recommended.
What if you forget to take Planetica 50 Injection :
Omit a scheduled Planetica 50 Injection? Seek medical advice immediately.
Facts to Know About Planetica 50 Injection
| Label | Value |
|---|---|
| Pharmaceutical Classification | Platinum-based compounds |
| Potential for Dependence | None. |
| Type of Medication | Cancer therapies |
| Mechanism of Action | Platinum-based antitumor agents |
3,018 People bought this recently